Cytosorbents Corporation (CTSO): Price and Financial Metrics
CTSO Price/Volume Stats
| Current price | $0.85 | 52-week high | $1.61 |
| Prev. close | $0.90 | 52-week low | $0.70 |
| Day low | $0.84 | Volume | 58,800 |
| Day high | $0.92 | Avg. volume | 198,041 |
| 50-day MA | $1.00 | Dividend yield | N/A |
| 200-day MA | $1.03 | Market Cap | 53.22M |
CTSO Stock Price Chart Interactive Chart >
Cytosorbents Corporation (CTSO) Company Bio
CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer technology. The company was founded in 1997 and is based in Monmouth Junction, New Jersey.
CTSO Price Returns
| 1-mo | N/A |
| 3-mo | -30.33% |
| 6-mo | -4.49% |
| 1-year | -13.21% |
| 3-year | -59.72% |
| 5-year | -91.75% |
| YTD | -6.59% |
| 2024 | -18.02% |
| 2023 | -28.39% |
| 2022 | -63.01% |
| 2021 | -47.43% |
| 2020 | 107.01% |
Continue Researching CTSO
Want to see what other sources are saying about Cytosorbents Corp's financials and stock price? Try the links below:Cytosorbents Corp (CTSO) Stock Price | Nasdaq
Cytosorbents Corp (CTSO) Stock Quote, History and News - Yahoo Finance
Cytosorbents Corp (CTSO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...